CD274 and neoplasm: Taken together, these results show that targeting PTIS has minimal or even growth promoting effects in untreated tumors yet, after acquired resistance to PD-L1 inhibition, tumors have a unique IFN-regulated vulnerability linked to PTIS expression that, when targeted directly or indirectly, has enhanced anti-tumor potency (Fig. 7F; Fig. 7G shows summary graphic).